Drug Discovery market research reports by Reach Market Research

• Sickle Cell Disease

  Aug 26, 2024  |  Published by: Reach Market Research  |  USD 17,150

  Sickle Cell Disease MarketVue®: Sickle Cell Disease (SCD) The MarketVue®: Sickle Cell Disease market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease ov ... Read More

• Prion Disease

  Aug 21, 2024  |  Published by: Reach Market Research  |  USD 17,150

  Prion Disease MarketVue®: Prion Disease The MarketVue®: Prion Disease market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidemiology (US ... Read More

• Gout (Chronic Refractory)

  Feb 23, 2024  |  Published by: Reach Market Research  |  USD 17,150

  MarketVue®: Chronic Refractory Gout The MarketVue®: Chronic Refractory Gout market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease over ... Read More

• Angelman Syndrome

  Feb 09, 2024  |  Published by: Reach Market Research  |  USD 17,150

  MarketVue®: Angelman Syndrome The MarketVue®: Angelman Syndrome market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidemiology (US and E ... Read More

• Tardive Dyskinesia (TD)

  Jan 01, 2024  |  Published by: Reach Market Research  |  USD 17,150

  MarketVue®: Tardive Dyskinesia (TD) The MarketVue®: Tardive Dyskinesia (TD) market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease over ... Read More

• Long QT Syndrome (LQTS)

  Oct 06, 2023  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Long QT Syndrome (LQTS) The MarketVue®: Long QT Syndrome (LQTS) market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidemiolo ... Read More

• Arrhythmogenic Cardiomyopathy (ACM)

  Oct 06, 2023  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Arrhythmogenic Cardiomyopathy The MarketVue®: Arrhythmogenic Cardiomyopathy market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview ... Read More

• Geographic Atrophy

  Jul 14, 2023  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Geographic Atrophy (GA) The MarketVue®: Geographic Atrophy market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, ... Read More

• Graves' Disease

  Jun 30, 2023  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Graves’ Disease The MarketVue®: Graves’ Disease market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidemiolo ... Read More

• Atopic Dermatitis (Dupixent-Refractory)

  Jun 08, 2023  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Dupixent-refractory atopic dermatitis (AD) The MarketVue®: Dupixent-refractory atopic dermatitis market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every M ... Read More

• Membranous Nephropathy

  Apr 21, 2023  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Membranous Nephropathy The MarketVue®: Membranous Nephropathy market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overvi ... Read More

• Classical Homocystinuria

  Mar 15, 2023  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Homocystinuria The MarketVue®: Homocystinuria market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidemiology (US and EU5), c ... Read More

• Delayed Onset Type 1 Diabetes

  Mar 01, 2023  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Delaying onset of Type 1 Diabetes The MarketVue®: delaying onset of Type 1 Diabetes market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® inc ... Read More

• Frontal Fibrosing Alopecia

  Jan 20, 2023  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Frontal Fibrosing Alopecia The MarketVue®: Frontal Fibrosing Alopecia market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a diseas ... Read More

• Pemphigus Vulgaris

  Jan 01, 2023  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Pemphigus Vulgaris The MarketVue®: Pemphigus Vulgaris market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epid ... Read More

• ANCA-Associated Vasculitis

  Jan 01, 2023  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis The MarketVue®: ANCA-associated vasculitis market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the mar ... Read More

• Idiopathic Inflammatory Myopathies

  Jan 01, 2023  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Idiopathic inflammatory myopathies (IIMs) The MarketVue®: Idiopathic inflammatory myopathies market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every Marke ... Read More

• Myasthenia Gravis

  Nov 23, 2022  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Myasthenia Gravis The MarketVue®: Myasthenia Gravis market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidem ... Read More

• Pancreatic Ductal Adenocarcinoma (PDAC)

  Nov 04, 2022  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Pancreatic Ductal Adenocarcinoma (PDAC) The MarketVue®: Pancreatic Ductal Adenocarcinoma (PDAC) market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every Ma ... Read More

• Celiac Disease

  Oct 28, 2022  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Celiac Disease The MarketVue®: Celiac Disease market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidemiology ... Read More

• Eosinophilic Esophagitis

  Oct 21, 2022  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Eosinophilic Esophagitis The MarketVue®: Eosinophilic Esophagitis market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease ov ... Read More

• Netherton Syndrome

  Oct 14, 2022  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Netherton’s Syndrome The MarketVue®: Netherton’s Syndrome market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidemiology (US ... Read More

• Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Jul 29, 2022  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) The MarketVue®: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a com ... Read More

• Paroxysmal Nocturnal Hemoglobinuria (PNH)

  Jul 21, 2022  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Paroxysmal Nocturnal Hemoglobinuria (PNH) The MarketVue®: Paroxysmal Nocturnal Hemoglobinuria (PNH) market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Ever ... Read More

• Cold Agglutinin Disease (CAD)

  Jul 01, 2022  |  Published by: Reach Market Research  |  USD 12,250

  MarketVue®: Cold Agglutinin Disease The MarketVue®: Cold Agglutinin Disease market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease over ... Read More

< prev 1 2 next >